Harikrishna Institute Of Oncology Private Limited - Company Profile

It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 Hyderabad, Telangana, India Amalgamated
Last Updated:
Access Report
About Harikrishna Institute Of Oncology Private Limited

Harikrishna Institute Of Oncology Private Limited, a amalgamated private limited company, was established on 03 October 2020 in Hyderabad, Telangana, India. Engaging in oncology clinics & cancer treatment within the healthcare sector, it holds CIN: U85190TG2020PTC144475. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.99 Cr and a paid-up capital of ₹3.51 Cr.

It upholds a compliant status. Its leadership includes Mohan Vamsy Chigurupati (Additional Director), Padmaja Chigurupati (Additional Director), Durga Naveen Vannemreddy (Director). It holds ₹118.73 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 12-10-587/50/9/1, Indranagar,102 Balaji Arcade,Sitapalmadi, Hyderabad, Telangana, 500061.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85190TG2020PTC144475

  • Registration Number

    144475

  • Incorporation Date

    03 October 2020

  • Authorized Capital

    ₹4.99 Cr

  • Paid-Up Capital

    ₹3.51 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 4.99 Cr
  • Paid Up Capital ₹ 3.51 Cr
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 118.73 Cr
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth ****
  • Total Assets **** 59103.25%
Company report

Harikrishna Institute Of Oncology Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Harikrishna Institute Of Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Harikrishna Institute Of Oncology Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohan Vamsy Chigurupati Additional Director 05 Oct 2022 Current
Padmaja Chigurupati Additional Director 05 Oct 2022 Current
Durga Naveen Vannemreddy Director 03 Oct 2020 Current
Sushila Narayan Director 03 Oct 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Harikrishna Institute Of Oncology.

Harikrishna Institute Of Oncology Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Harikrishna Institute Of Oncology revenue growth over time
Harikrishna Institute Of Oncology profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 59103.25%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Harikrishna Institute Of Oncology?

In 2022, Harikrishna Institute Of Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,187,336,406.20

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 104.94 Cr
  • Axis Bank Limited : 10.08 Cr
  • Others : 3.71 Cr
Latest Charge Details
Date Lender Amount Status
31 Jan 2023 Others ₹5.78 M Open
06 Jan 2023 Axis Bank Limited ₹8.20 Cr Open
06 Jan 2023 Axis Bank Limited ₹1.88 Cr Open
30 Dec 2022 Others ₹1.06 Cr Open
14 Dec 2022 Others ₹2.07 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Harikrishna Institute Of Oncology?

Harikrishna Institute Of Oncology has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Harikrishna Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harikrishna Institute Of Oncology's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Harikrishna Institute Of Oncology
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others amounted to Rs. 0.58 Cr with Charge ID 100677206 was registered on 31 Jan 2023. was documented.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 8.20 Cr with Charge ID 100668933 was registered on 06 Jan 2023. was documented.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 1.88 Cr with Charge ID 100665733 was registered on 06 Jan 2023. was completed.

  • Charges

    A charge with Others amounted to Rs. 1.06 Cr with Charge ID 100669869 was registered on 30 Dec 2022. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 2.07 Cr with Charge ID 100661350 was registered on 14 Dec 2022. was recorded as a recent event.

  • Director Appointment

    Mohan Vamsy Chigurupati was appointed as a Additional Director was appointed as a Additional Director on 05 Oct 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Harikrishna Institute Of Oncology Private Limited?

The CIN of Harikrishna Institute Of Oncology Private Limited is U85190TG2020PTC144475.

Where is Harikrishna Institute Of Oncology Private Limited headquartered?

Harikrishna Institute Of Oncology Private Limited is headquartered at 12-10-587/50/9/1, Indranagar,102 Balaji Arcade,Sitapalmadi, Hyderabad, Telangana, 500061.

When was Harikrishna Institute Of Oncology Private Limited incorporated?

Harikrishna Institute Of Oncology Private Limited was incorporated on 03 October 2020.

Who are the current directors of Harikrishna Institute Of Oncology Private Limited?

The current directors of Harikrishna Institute Of Oncology Private Limited are

What is the primary industry of Harikrishna Institute Of Oncology Private Limited?

The primary industry of Harikrishna Institute Of Oncology Private Limited is Healthcare.

Is Harikrishna Institute Of Oncology Private Limited a listed company?

Harikrishna Institute Of Oncology Private Limited is unlisted.

What is the capital structure of Harikrishna Institute Of Oncology Private Limited?

The authorized capital of Harikrishna Institute Of Oncology Private Limited is ₹4.99 Cr, and the paid-up capital is ₹3.51 Cr.

What is the compliance status of Harikrishna Institute Of Oncology Private Limited?

The compliance status of Harikrishna Institute Of Oncology Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available